Stockreport

Acorda Therapeutics Q4 revenues up 34%; updates guidance [Seeking Alpha]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Acorda Therapeutics Q4 revenues up 34%; updates guidanceAcorda Therapeutics (ACOR)Q4 results: Revenues: $188.4M (+34.0%); Operating Loss: ($218.1M); Net Loss: ($171.1M); [Read more]